Aveanna Healthcare Holdings (AVAH) Gains from Sales and Divestitures (2022 - 2026)

Aveanna Healthcare Holdings (AVAH) has reported Gains from Sales and Divestitures for 4 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.

• Gains from Sales and Divestitures for Q1 2026 came in at $5.7 million, up 728.53% year-over-year; the trailing twelve-month figure through Jan 2026 was $5.7 million (up 728.53% YoY), and the FY2026 annual result was $5.7 million, up 728.53% from the prior year.
• Gains from Sales and Divestitures was $5.7 million for Q1 2026 at Aveanna Healthcare Holdings, up from $688865.0 in the prior quarter.
• Over five years, Gains from Sales and Divestitures peaked at $5.7 million in Q1 2026 and troughed at $308055.0 in Q4 2023.
• Average Gains from Sales and Divestitures over 4 years is $1.8 million, with a median of $504959.0 recorded in 2022.
• Year-over-year, Gains from Sales and Divestitures slipped 4.05% in 2023 and surged 728.53% in 2026.
• Over 4 years, Gains from Sales and Divestitures stood at $321053.0 in 2022, then retreated by 4.05% to $308055.0 in 2023, then soared by 123.62% to $688865.0 in 2024, then surged by 728.53% to $5.7 million in 2026.
• Per Business Quant data, the three most recent Gains from Sales and Divestitures figures were $5.7 million in Q1 2026, $688865.0 in Q4 2024, and $308055.0 in Q4 2023.